Drug Evaluation during the Covid-19 Pandemic

New England Journal of Medicine
June 11, 2020 Vol. 382 No. 24


Drug Evaluation during the Covid-19 Pandemic
Benjamin N. Rome, M.D., and Jerry Avorn, M.D.
The search for a treatment for Covid-19 is testing our country’s ability to quickly develop, test, and deploy medications, presenting both opportunities and challenges to our drug-assessment apparatus. Several aspects of the U.S. response raise serious concerns, highlighting how the processes for evaluating and approving drugs can go awry during a public health crisis…